What is the best management approach for a patient with ureteropelvic junction obstruction (UPJO) caused by schistosomiasis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Ureteropelvic Junction Obstruction (UPJO) Caused by Schistosomiasis

Treat all patients with UPJO secondary to schistosomiasis with praziquantel 40 mg/kg as a single oral dose, followed by surgical intervention (ureteral resection with reconstruction or pyeloplasty) if significant obstruction persists after antiparasitic therapy, as medical treatment alone cannot reverse established fibrotic strictures. 1, 2, 3

Initial Diagnostic Workup

Confirm Active Schistosomal Infection

  • Obtain microscopy of terminal urine samples to detect Schistosoma haematobium eggs, as this confirms active infection requiring treatment 4
  • Test for endemic coinfections including Salmonella, HBV, HCV, and HIV, as these may alter disease aggressiveness and treatment approach 1, 5
  • Perform renal ultrasound to assess degree of hydronephrosis and identify ureteral dilation or stricture 1

Assess Severity of Obstruction

  • Obtain Tc-99m MAG3 renal scan to evaluate split renal function and drainage, as this determines urgency of intervention 1
  • Consider CT or MRI for detailed anatomical assessment of the ureteropelvic junction and surrounding structures, particularly to exclude malignancy which can mimic schistosomal obstruction 6
  • Evaluate for bladder cancer and urinary obstruction in patients with elevated creatinine and/or hematuria, as these are common complications of S. haematobium 1, 5

Medical Management

Antiparasitic Treatment

  • Administer praziquantel 40 mg/kg orally as a single dose immediately upon diagnosis 1, 2, 5
  • Repeat praziquantel 40 mg/kg at 6-8 weeks after initial treatment, as immature schistosomules are relatively resistant to initial therapy 2, 4
  • Do not use immunosuppressive agents in schistosomal nephropathy or urinary tract disease, as these provide no benefit and may worsen outcomes 1, 5

Symptomatic Management

  • Consider short course of oral prednisolone 20 mg daily for 5 days if acute inflammatory symptoms are severe, though this does not affect cure rates 2, 4

Surgical Intervention

Indications for Surgery

Proceed with surgical intervention when any of the following criteria are met after completing antiparasitic therapy:

  • T1/2 >20 minutes on diuretic renal scan indicating persistent obstruction 1
  • Differential renal function <40% on affected side 1
  • Deteriorating function with >5% decrease on consecutive renal scans 1
  • Progressive hydronephrosis on serial ultrasound despite medical treatment 3, 7

Surgical Options

  • Perform ureteral resection with Boari flap and psoas hitch reconstruction for lower ureteral strictures with severe fibrosis 3
  • Consider open, laparoscopic, or robotic pyeloplasty for ureteropelvic junction strictures 8
  • Place percutaneous nephrostomy for temporary drainage in patients with severe uremia or acute obstruction while planning definitive surgery 7
  • Use ureteral stenting for attempted recannalization in select cases, though definitive reconstruction is often ultimately required 7

Critical Timing Considerations

The key pitfall in schistosomal UPJO is delayed surgical intervention. Medical treatment with praziquantel eradicates the parasite but cannot reverse established fibrotic strictures 3, 6. Waiting too long after antiparasitic therapy risks progressive renal damage and irreversible loss of function 3, 7.

  • Complete both doses of praziquantel (initial and 6-8 week repeat) before surgical planning 2, 4
  • Reassess with renal scan 2-3 months after completing antiparasitic therapy to determine if obstruction persists 1
  • Do not delay surgery beyond 3-4 months post-treatment if objective evidence of obstruction remains, as progressive renal deterioration is likely 3, 7

Monitoring and Follow-up

  • Perform serial ultrasound every 3-6 months after surgery to monitor for recurrent obstruction 1
  • Repeat renal scan if differential function was impaired pre-operatively to document improvement or stability 1
  • Do not use serology to assess treatment success, as antibodies persist for years after successful parasite eradication 2, 4, 5
  • Monitor for bladder complications including stones, strictures, and malignancy with periodic cystoscopy in patients with history of urinary schistosomiasis 7, 6

Special Populations

Patients with Renal Insufficiency

  • Initiate maintenance hemodialysis if severe uremia is present while planning definitive surgical management 7
  • Prioritize early surgical decompression to preserve remaining renal function 3, 7

Bilateral Disease

  • Stage surgical interventions, addressing the side with worse function first 7
  • Consider bilateral percutaneous nephrostomy for initial stabilization if both kidneys are severely obstructed 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Bilharzia (Schistosomiasis)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Ureteric schistosomiasis with obstructive uropathy.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2009

Guideline

Treatment of Recurrent Urinary Schistosomiasis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Perirenal Adenopathy Associated with Schistosoma Hematobium

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Ureteral obstruction caused by schistosomiasis.

JBR-BTR : organe de la Societe royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie (KBVR), 2013

Related Questions

What is the best treatment approach for a patient with ureteropelvic junction obstruction (UPJO) caused by schistosomiasis?
What is the best course of treatment for a patient in their 40s with a history of longstanding back pain, recently diagnosed with a partial right ureteropelvic junction (UPJ) obstruction, mild hydronephrosis, and a large post-void residual urine volume, with normal prostate size and no urinary tract infections?
Are renal stones more uncomfortable when located at the ureteropelvic junction (UPJ) or in the lower pole of the kidney?
What is the treatment for mild left hydroureteronephrosis secondary to a 2mm calculus at the left ureterovesical junction?
What is the best management for a 78-year-old man with stage IV (four) adenocarcinoma of the prostate, presenting with left hydronephrosis (kidney swelling due to obstruction) and impaired renal function (elevated serum creatinine), after previous treatment with bilateral orchiectomy (surgical removal of testes)?
Can Polycythemia Vera (PV) cause heavy uterine bleeding in females of reproductive age?
What is the best management approach for a patient presenting with fever and dysuria (painful urination)?
What is the recommended dosage of magnesium (Mg) supplementation for a patient with Bartter syndrome, considering Mg supplements are only available in antacids?
What is the average amount of deep sleep a healthy adult gets per night and how much is recommended?
What is the recommended treatment and management for gonorrhea in sexually active women, including those with potential co-infections and allergies?
What are the medical explanations, other than polycythemia vera (PV), for elevated red blood cell count, hematocrit, and hemoglobin levels in a patient?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.